BioCryst Pharmaceuticals, Inc. ikhonkco yemakethe

BioCryst Pharmaceuticals, Inc. i-capital capital

Namhlanje i-market capital BioCryst Pharmaceuticals, Inc. ingu-1 583 271 296 US dollar.

+190 923 648 $ (+13.71%)

utshintsho lwentengo ukususela ngezolo

BioCryst Pharmaceuticals, Inc. capitalization kwiidola namhlanje. BioCryst Pharmaceuticals, Inc. ingxowankulu ulwazi oluvulekileyo. BioCryst Pharmaceuticals, Inc. capitalisation ibalwa ngokusekelwe kuthengiso lwesitokhwe. BioCryst Pharmaceuticals, Inc. i-cap cap namhlanje ilingana no-1 583 271 296 iidola zaseMelika.

BioCryst Pharmaceuticals, Inc. ivolumu yezorhwebo

Namhlanje inani lemali yokuthengisa BioCryst Pharmaceuticals, Inc. lingama-3 794 784 US dollar.

+466 347 $ (+14.01%)

utshintsho lwendleko yorhwebo ukususela ngezolo

BioCryst Pharmaceuticals, Inc. ithengiswa kwiiwebhusayithi ezahlukeneyo zorhwebo. Itshathi yemihla ngemihla yokurhweba ye BioCryst Pharmaceuticals, Inc. ikwiwebhusayithi yethu. BioCryst Pharmaceuticals, Inc. yokuthengisa kwi-intanethi ebanjwa kakhulu kwi-intanethi ethengisa izinto ezininzi, iwebhusayithi yethu ibonisa inani elipheleleyo lokurhweba BioCryst Pharmaceuticals, Inc. ngosuku. BioCryst Pharmaceuticals, Inc. i-capitalization ikhula nge- $ 190 923 648.

Bonisa: BioCryst Pharmaceuticals, Inc. (BCRX) Ukuze US dollar (USD)

BioCryst Pharmaceuticals, Inc. istatshi yekhredithi yemakethe

BioCryst Pharmaceuticals, Inc. itshathi yemalike yeminyaka ngeminyaka. 12.17% ngeveki - utshintsho kutshintsho lweentengiso BioCryst Pharmaceuticals, Inc.. Ngaphezulu kwenyanga, BioCryst Pharmaceuticals, Inc. capitalisation itshintshwe ngu 0%. BioCryst Pharmaceuticals, Inc. ikhonkco yentengiso iyenyuka.

Iveki

Inyanga

iinyanga 3

Unyaka

Iminyaka emithathu

BioCryst Pharmaceuticals, Inc. imbali yenkxaso-mali

Umhla	Ixabiso Imali-mali (intengo-mali yemarike) yixabiso lemarike yazo zonke izabelo zeenkampani ezithengiswa kwi-stock exchange. Imali yentengo yemali ilingana nexabiso lezabelo ezandisiwe ngenani lezabelo ezikhoyo.
03/05/2023	1 583 271 296 $
02/05/2023	1 392 347 648 $
01/05/2023	1 426 353 536 $
28/04/2023	1 430 343 168 $
27/04/2023	1 419 036 160 $
26/04/2023	1 421 862 912 $
25/04/2023	1 411 497 984 $

BioCryst Pharmaceuticals, Inc. isatifiketi somqulu

Iveki

Inyanga

iinyanga 3

Unyaka

Iminyaka emithathu

BioCryst Pharmaceuticals, Inc. idatha yembali yevolumu

Umhla	Umqulu (24h) Ixabiso lezorhwebo leBioCryst Pharmaceuticals, Inc. izabelo yintlawulo yenani lazo zonke iintengiso kunye neengxenye ze-BCRX ezithengiweyo kwaye zathengiswa ngexesha lomhla okhethiweyo.
03/05/2023	3 794 784 $
02/05/2023	3 328 437 $
01/05/2023	1 002 561 $
28/04/2023	370 085 $
27/04/2023	1 912 096 $
26/04/2023	543 413 $
25/04/2023	2 062 315 $

03/05/2023 BioCryst Pharmaceuticals, Inc. capitalised eyi- 1 583 271 296 iidola zaseMelika. BioCryst Pharmaceuticals, Inc. capitalization e 02/05/2023 ifikelele kuthi 1 392 347 648 iidola zaseMelika. Iimali yentengiso enkulu ye BioCryst Pharmaceuticals, Inc. kwi 01/05/2023 ifikelele kuthi 1 426 353 536 iidola zaseMelika. BioCryst Pharmaceuticals, Inc. capitalization e 28/04/2023 ifikelele kuthi 1 430 343 168 iidola zaseMelika.

27/04/2023 BioCryst Pharmaceuticals, Inc. capitalised eyi- 1 419 036 160 iidola zaseMelika. Iimali yentengiso enkulu ye BioCryst Pharmaceuticals, Inc. ifikelele kwi 1 421 862 912 Iidola zaseMelika ku- 26/04/2023. Iimali yentengiso enkulu ye BioCryst Pharmaceuticals, Inc. kwi 25/04/2023 ifikelele kuthi 1 411 497 984 iidola zaseMelika.

Inkcitho ye-BioCryst Pharmaceuticals, Inc. namhlanje ngu-1 583 271 296 $. Iimali zentengiso ye-BioCryst Pharmaceuticals, Inc. ishintshile +13.71% xa kuthelekiswa nezolo. Imali yokuthengisa ye BCRX izabelo ze BioCryst Pharmaceuticals, Inc. ngosuku lokugqibela lokurhweba lilinganiselwa kuma-3 794 784 $. Ixabiso lokuthengiswa kwezabelo ze BioCryst Pharmaceuticals, Inc. latshintshile kwi-+14.01% xa kuthelekiswa nosuku lwangaphambili lworhwebo.